Biographical summary
- My long term goal is to understand molecular mechanisms underlying myeloid disorders/leukemia and to develop innovative strategies to improve its clinical outcome.
- My interest in leukemia and myeloid disorders is derived from years of clinical training.
- Training in different hospitals and different countries helped me to developed diverse clinical perspective to solve important clinical problems.
- My aim is to provide compassionate care to my patients with best of my abilities, empowering them to make rationalized decision.
Conditions treated
Interests
My interest is in acute leukemia, myeloid disorders and cellular therapy.
Mayo Clinic locations
Education
- 2020
Fellowship - Hematology and OncologyMedical College of Wisconsin
- 2017
Residency - Internal MedicineBrandon Regional Hospital
- 2015
Fellowship - Clinical LeukemiaUniversity of Texas MD Anderson Cancer Center
- 2013
Fellowship - Medical OncologyCollege of Physicians and Surgeons Pakistan
- 2009
Residency - Internal MedicineCollege of Physicians and Surgeons Pakistan
- 2006
MBBSJinnah Medical and Dental College
Activities and honors
Certifications
- 2020
HematologyAmerican Board of Internal Medicine
- 2020
Medical OncologyAmerican Board of Internal Medicine
- 2017
Internal MedicineAmerican Board of Internal Medicine
Awards and honors
- 2019
Outstanding Fellow Research Award at Wisconsin Association of Hematology and Oncology (WAHO) Annual Meeting 2019.Wisconsin Association of Hematology and Oncology (WAHO)
- 2017
Best Resident Research Award, presented at Presented at HCA West Florida GME Consortium/Brandon Regional Hospital Annual Research Day, 2017.HCA West Florida GME Consortium/Brandon Regional Hospital
- 2017
People’s Choice Award for best research at Health Corporation of America West Division Annual Research Day, 2017.Health Corporation of America West Division
- 2015
Future Leaders Award for Clinical Research in Hematology Celgene
- 2014
Best Abstract Achievement Award, presented at American Society of Hematology Annual Meeting, 2014.American Society of Hematology
- 2014
Best oral abstract “Outcome of FLT3 ITD Mutated AML Patients Based on Different Treatment Strategies”. Presented at Society of Hematology Oncology Annual meeting 2014, Houston, Texas, USA.Society of Hematology and Oncology
- 2004
Final Professional Annual: Distinction in Surgery and ENT and Overall Class Rank: SecondJinnah Medical and Dental College
- 2003
Third Professional Annual: Distinction in Community Medicine and Overall Class Rank: Second.Jinnah Medical and Dental College
- 2002
Second Professional Annual: Overall Class Rank: Third.Jinnah Medical and Dental College
- 2001
First Professional Part B: Distinction in Biochemistry, Physiology and Anatomy with Overall Class Rank: First.Jinnah Medical and Dental College
- 2000
First Professional Part A: Distinction in Biochemistry, Physiology and Anatomy with Overall Class Rank: Third.Jinnah Medical and Dental College
Professional memberships
- 2022 - present
Active MemberData Safety Monitoring Committee, Mayo Clinic Cancer Center; Data Safety Monitoring Committee
- 2022 - present
MemberData Safety Monitoring Board
- 2021 - present
MemberScientific Review Committee A, Mayo Clinic Cancer Center
- 2021 - present
Associate MemberMayo Clinic Cancer Center
- 2021 - present
Associate Board MemberMayo Clinic Comprehensive Cancer Center
- 2020 - present
MemberECOG-ACRIN Leukemia Committee
- 2020 - present
Member-at-LargeFlorida Society of Clinical Oncology
- 2020 - present
InvestigatorNational Cancer Institute, National Institutes of Health
- 2017 - present
Committee MemberCIBMTR Acute Leukemia Working Committee
- 2017 - present
Committee MemberCIBMTR Chronic Leukemia Working Committee
- 2017 - present
Committee MemberCIBMTR Cellular Therapy Working Committee Member
- 2017 - present
MemberAmerican Society of Hematology
- 2017 - present
Committee Member and Reviewer, Futures Grants InvestigatorCenter for International Blood and Marrow Transplant Research (CIBMTR)
Publications